A Rare Case – Placental Site Trophoblastic Tumor

Authors

  • Dr. Mukti S. Harne
  • Dr. A. A. Solanke
  • Dr. S. K. Rath
  • Dr. Urmila Gawali

Keywords:

Gestational Trophoblastic diseases, Molar pregnancy, Placental tumour

Abstract

Background: Gestational trophoblastic disease is an umbrella term for a group of pregnancy related disorders arising from abnormal placental trophoblast cells. It may follow either molar pregnancy, non-molar term pregnancy or first-trimester non-molar miscarriage. Persistent gestational trophoblastic disease is potentially fatal, but majority of patients are cured with chemotherapy.

Downloads

Download data is not yet available.

References

N.J.Sebire, R. A. Fisher, M. Foskett, H. Rees, M. J. Seckl, and E. S. Newlands, "Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy," British Journal of Obstetrics and Gynaecology, vol. 110, no.1, pp. 22-26, 2003.

Royal College of Obstetricians and gynaecologists, "The management of Gestational Trophoblastic "Thedisease," RCOG Green Top Guideline NO. 38, 2009.

F. Flam, F. Petterson, and V. Lundstrom, "Medical induction prior to Surgical evacuation of of Hydatidiform mole. Is there a greater risk persistent gestational trophoblastic disease?European Journal of Obstetrics and Gyneco Of and Reproductive Biology, vol. 42, pp. 57-60. 1991.

M. Stone and K. D. Bagshawe, "An analysis of influences of maternal age, gestational age, contraceptive method, and the mode of , primary treatment of patients with hydatidiforr moles on the incidence of subsequent chemotherapy," British Journal of Obstetrics and Gynaecology, vol. 86, no 10, pp. 782-792, 1979.

M. Pezeshki, B. W. Hancock, P. Silcocks et al. "The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease," Gynecologic Oncology, vol. 95, no. 3, pp. 423-429, 2004.

N. Pisal, J. Tidy, and B. Hancock, "Gestational trophoblastic disease: is intensive follow up essential in all women?" British Journal of Obstetrics and Gynaecology, vol. 111, no. 12, p. 1449-1451,2004.

N. J. Sebire, M. Foskett, D. Short et al., "Shortened duration of human chorionic gonadotrophin surveillance following complete or partial hydatidiform mole: evidence for revised protocol of a UK regional trophoblastic disease unit," British Journal of Obstetrics and Gynaecology, vol. 114 no.6, pp. 760-762, 2007.

Dobson LS1, Lorigan PC, Coleman RE, HancooK BW. Persistent gestational trophoblastic disease results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomyui as second-line therapy for low risk disease. Br J Cancer. 2000 May;82(9):1547-52..

Downloads

Published

2015-09-11

How to Cite

Harne, D. M. S. ., Solanke, D. A. A. ., Rath , D. S. K., & Gawali, D. U. (2015). A Rare Case – Placental Site Trophoblastic Tumor. VIMS Health Science Journal, 2(3), 107–108. Retrieved from https://vimshsj.edu.in/index.php/main/article/view/183

Issue

Vol. 2 No. 3 (2015): September

Section

Case Report

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.